La Escuela de Medicina de Ponce La Escuela de Medicina de Ponce, es una entidad sin fines de lucro acreditada por el Liason Committee of Medical Education, fundada en el 1977, y es una de las más ...

During the past decade, Ponce School of Medicine CAIMED Center conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 22 clinical trials were completed, i.e. on average, 88% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 16 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ponce School of Medicine CAIMED Center" #1 sponsor was "Eli Lilly and Company" with 21 trials, followed by "Pfizer" with 4 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials sponsored and "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ponce School of Medicine CAIMED Center" #1 collaborator was "Incyte Corporation" with 4 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator and "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Ponce School of Medicine CAIMED Center" are "Plaque Psoriasis" (4 trials), "Rheumatoid Arthritis" (4 trials), "Atopic Dermatitis" (3 trials), "Migraine" (3 trials) and "Psoriasis" (2 trials). Many other conditions were trialed in "Ponce School of Medicine CAIMED Center" in a lesser frequency.

Most popular intervention types in "Ponce School of Medicine CAIMED Center" are "Drug" (29 trials), "Biological" (5 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (20 trials), "Baricitinib" (5 trials), "Ixekizumab" (4 trials), "Insulin Glargine" (3 trials) and "Mirikizumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Ponce School of Medicine CAIMED Center" are 35 trials for "All" genders.

Currently, there are NaN active trials in "Ponce School of Medicine CAIMED Center". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Ponce School of Medicine CAIMED Center, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Ponce School of Medicine CAIMED Center, 2 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".